| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |